BR112012013761A2 - quelatos de manganês e seu uso como os agentes de contraste na formação de imagem pela ressonância magnética (mri) - Google Patents
quelatos de manganês e seu uso como os agentes de contraste na formação de imagem pela ressonância magnética (mri)Info
- Publication number
- BR112012013761A2 BR112012013761A2 BR112012013761A BR112012013761A BR112012013761A2 BR 112012013761 A2 BR112012013761 A2 BR 112012013761A2 BR 112012013761 A BR112012013761 A BR 112012013761A BR 112012013761 A BR112012013761 A BR 112012013761A BR 112012013761 A2 BR112012013761 A2 BR 112012013761A2
- Authority
- BR
- Brazil
- Prior art keywords
- magnetic resonance
- resonance imaging
- mri
- contrast agents
- manganese chelates
- Prior art date
Links
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 title abstract 3
- 238000002595 magnetic resonance imaging Methods 0.000 title abstract 3
- 229910052748 manganese Inorganic materials 0.000 title abstract 3
- 239000011572 manganese Substances 0.000 title abstract 3
- 239000002872 contrast media Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/12—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20093555A NO331773B1 (no) | 2009-12-18 | 2009-12-18 | Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR) |
| PCT/EP2010/070029 WO2011073371A1 (en) | 2009-12-18 | 2010-12-17 | Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012013761A2 true BR112012013761A2 (pt) | 2016-04-26 |
Family
ID=43770529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012013761A BR112012013761A2 (pt) | 2009-12-18 | 2010-12-17 | quelatos de manganês e seu uso como os agentes de contraste na formação de imagem pela ressonância magnética (mri) |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9486544B2 (https=) |
| EP (1) | EP2512524B1 (https=) |
| JP (1) | JP5879268B2 (https=) |
| KR (1) | KR101860160B1 (https=) |
| CN (1) | CN102639152B (https=) |
| AU (1) | AU2010332760B2 (https=) |
| BR (1) | BR112012013761A2 (https=) |
| CA (1) | CA2781228A1 (https=) |
| DK (1) | DK2512524T3 (https=) |
| ES (1) | ES2606165T3 (https=) |
| HR (1) | HRP20161627T1 (https=) |
| HU (1) | HUE032152T2 (https=) |
| LT (1) | LT2512524T (https=) |
| MX (1) | MX2012007041A (https=) |
| NO (1) | NO331773B1 (https=) |
| PL (1) | PL2512524T3 (https=) |
| PT (1) | PT2512524T (https=) |
| RU (1) | RU2561718C2 (https=) |
| WO (1) | WO2011073371A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105142649A (zh) | 2013-04-26 | 2015-12-09 | 法国加柏公司 | 造影剂配制品与有关制备方法 |
| EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
| US10568976B2 (en) | 2015-11-26 | 2020-02-25 | Debreceni Egyetem | 3,6,9, 15-tetraaza-bicyclo [9.3.1 ]pentadeca-1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents |
| WO2017089848A1 (en) | 2015-11-26 | 2017-06-01 | Debreceni Egyetem | New 2, 1 l -diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based mri contrast agents and 52mn based pet contrast agents |
| EP3380484A1 (en) | 2015-11-26 | 2018-10-03 | Debreceni Egyetem | New 6-oxa-3,9, 15-triaza-bicyclo[9.3.1 ]pentadec a- 1 ( 14), 1 1 ( 15), 12-triene derivatives based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents |
| GB201610738D0 (en) * | 2016-06-20 | 2016-08-03 | Ge Healthcare As | Chelate compounds |
| ES2814555T3 (es) | 2016-11-28 | 2021-03-29 | Bayer Pharma AG | Compuestos de quelato de gadolinio con alta relaxividad para usar en la obtención de imágenes por resonancia magnética |
| JP7258753B2 (ja) | 2016-12-21 | 2023-04-17 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | Ｍｒｉイメージング剤として好適なテトラアザビシクロ大員環系マンガンキレート化合物 |
| EP3728168B1 (en) * | 2017-12-20 | 2022-03-30 | General Electric Company | Anionic chelate compounds |
| KR102934987B1 (ko) | 2018-11-23 | 2026-03-09 | 바이엘 악티엔게젤샤프트 | 조영 매체의 제형 및 그의 제조 방법 |
| CN111233982B (zh) * | 2018-11-28 | 2023-03-03 | 深圳先进技术研究院 | 一种小分子蛋白质及其应用 |
| LT4025259T (lt) | 2019-09-03 | 2025-02-10 | Ge Healthcare As | Mangano chelato izomerai |
| CN114874214B (zh) * | 2022-05-31 | 2023-03-21 | 南京航空航天大学 | 可偶联巯基的双功能大环螯合剂衍生物及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU608759B2 (en) | 1986-08-04 | 1991-04-18 | Amersham Health Salutar Inc | NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes |
| DE3640708C2 (de) | 1986-11-28 | 1995-05-18 | Schering Ag | Verbesserte metallhaltige Pharmazeutika |
| US5334371A (en) * | 1988-07-20 | 1994-08-02 | Schering Aktiengesellschaft | Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI |
| HUT59014A (en) | 1988-09-27 | 1992-04-28 | Salutar Inc | Process for producing diagnostic compositions comprising chelates |
| EP0570575B1 (en) * | 1991-12-10 | 1997-12-10 | The Dow Chemical Company | Bicycloazamacrocyclophosphonic acid, conjugates, contrast agents and preparation |
| WO1994026313A1 (en) * | 1993-05-06 | 1994-11-24 | The Dow Chemical Company | Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents |
| US5428139A (en) * | 1991-12-10 | 1995-06-27 | The Dow Chemical Company | Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals |
| DE69230970T2 (de) * | 1991-12-10 | 2001-01-04 | The Dow Chemical Co., Midland | Bicylclische, polyazamakrocyclocarbonsäure-komplexe, konjugate, herstellung und verwendung als kontraststoffe |
| FR2836916B1 (fr) * | 2002-03-05 | 2004-06-11 | Guerbet Sa | Oligomeres de chelates de gadolinium, leur application comme produits de contraste en imagerie par resonance magnetique et leurs intermediaires de synthese |
| FR2856689A1 (fr) * | 2003-06-25 | 2004-12-31 | Guerbet Sa | Composes specifiques a forte relaxivite |
| WO2006080022A2 (en) * | 2005-01-31 | 2006-08-03 | Yeda Research And Development Co. Ltd. | Mri contrast agents for diagnosis and prognosis of tumors |
-
2009
- 2009-12-18 NO NO20093555A patent/NO331773B1/no unknown
-
2010
- 2010-12-17 CA CA2781228A patent/CA2781228A1/en not_active Abandoned
- 2010-12-17 BR BR112012013761A patent/BR112012013761A2/pt not_active Application Discontinuation
- 2010-12-17 EP EP10805224.2A patent/EP2512524B1/en active Active
- 2010-12-17 US US13/510,064 patent/US9486544B2/en active Active
- 2010-12-17 HU HUE10805224A patent/HUE032152T2/en unknown
- 2010-12-17 AU AU2010332760A patent/AU2010332760B2/en not_active Ceased
- 2010-12-17 KR KR1020127015488A patent/KR101860160B1/ko not_active Expired - Fee Related
- 2010-12-17 JP JP2012543778A patent/JP5879268B2/ja active Active
- 2010-12-17 PL PL10805224T patent/PL2512524T3/pl unknown
- 2010-12-17 CN CN201080056567.0A patent/CN102639152B/zh active Active
- 2010-12-17 ES ES10805224.2T patent/ES2606165T3/es active Active
- 2010-12-17 WO PCT/EP2010/070029 patent/WO2011073371A1/en not_active Ceased
- 2010-12-17 RU RU2012124266/04A patent/RU2561718C2/ru not_active IP Right Cessation
- 2010-12-17 MX MX2012007041A patent/MX2012007041A/es not_active Application Discontinuation
- 2010-12-17 LT LTEP10805224.2T patent/LT2512524T/lt unknown
- 2010-12-17 PT PT108052242T patent/PT2512524T/pt unknown
- 2010-12-17 DK DK10805224.2T patent/DK2512524T3/en active
- 2010-12-17 HR HRP20161627TT patent/HRP20161627T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20120244081A1 (en) | 2012-09-27 |
| NO331773B1 (no) | 2012-03-26 |
| MX2012007041A (es) | 2012-07-20 |
| LT2512524T (lt) | 2016-12-12 |
| CN102639152A (zh) | 2012-08-15 |
| JP2013514329A (ja) | 2013-04-25 |
| RU2012124266A (ru) | 2014-01-27 |
| EP2512524A1 (en) | 2012-10-24 |
| NO20093555A1 (no) | 2011-06-20 |
| CN102639152B (zh) | 2015-11-25 |
| US9486544B2 (en) | 2016-11-08 |
| KR101860160B1 (ko) | 2018-05-21 |
| HUE032152T2 (en) | 2017-09-28 |
| DK2512524T3 (en) | 2017-01-09 |
| AU2010332760B2 (en) | 2016-01-07 |
| JP5879268B2 (ja) | 2016-03-08 |
| CA2781228A1 (en) | 2011-06-23 |
| HRP20161627T1 (hr) | 2017-01-13 |
| RU2561718C2 (ru) | 2015-09-10 |
| KR20120109505A (ko) | 2012-10-08 |
| AU2010332760A1 (en) | 2012-06-07 |
| EP2512524B1 (en) | 2016-10-05 |
| WO2011073371A1 (en) | 2011-06-23 |
| PT2512524T (pt) | 2016-12-15 |
| PL2512524T3 (pl) | 2017-08-31 |
| ES2606165T3 (es) | 2017-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012013761A2 (pt) | quelatos de manganês e seu uso como os agentes de contraste na formação de imagem pela ressonância magnética (mri) | |
| MX2012009088A (es) | Anticuerpos que se enlazan a lisil oxidasa-tipo2 (loxl2) y metodos de uso para los mismos. | |
| BR112014011594A2 (pt) | anticorpos anti-il-36r | |
| UY36711A (es) | Nuevos compuestos de quelatos de gadolinio para usar en imágenes de resonancia magnética | |
| CO6501196A2 (es) | Compuestos antiproliferativos, cojugados de los mismos, procedimientos para éstos y uso de los mismos | |
| MX367366B (es) | Composiciones y metodos para diagnosticar tumores de tiroides. | |
| EP2595664A4 (en) | MODULATION OF A CORE RNA | |
| EA201791850A1 (ru) | Борсодержащие малые молекулы | |
| CR11776A (es) | Inhibidores de bace | |
| CR10654A (es) | Agentes que comprenden compuestos marcados con 18f y metodos relacionados | |
| BRPI0809689A2 (pt) | Bobina de gradiente de campo magnético, escâner por ressonância magnética, e, escâner híbrido | |
| BRPI1014543B8 (pt) | Moléculas e composições pesticidas | |
| WO2011088193A3 (en) | Fluorophore chelated lanthanide luminiscent probes with improved quantum efficiency | |
| IL232176B (en) | Magnetic resonance maps for analyzing tissue | |
| DE602006002073D1 (de) | Supraleitender Magnet für Kerspintomographie | |
| BRPI0913833A2 (pt) | uso de corantes ácidos | |
| BR112014012892A2 (pt) | agentes de reversão anticoagulantes | |
| BRPI0913477A2 (pt) | "método para desenvolvimento de marcador diagnóstico" | |
| EP2625282A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF AUTISM | |
| BR112013003216A2 (pt) | composições sintéticas de ácido biliar e métodos | |
| EP2895205A4 (en) | BACTERIA-SPECIFIC MARKED SUBSTRATES AS IMAGING BIOMARKERS FOR THE DIAGNOSIS, LOCALIZATION AND MONITORING OF INFECTIONS | |
| IL209059A0 (en) | Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications | |
| MX2010010472A (es) | Tinturas dispersas de azopiridona, su preparacion y su uso. | |
| UY37500A (es) | Nuevos compuestos de quelato de gadolinio con alta relaxividad para usar en la obtencion de imagenes por resonancia magnetica | |
| BR112013000840A2 (pt) | método para aumentar o efeito de forma ativada potencializada de anticorpo para molécula endógena biológica, composição farmacêutica e uso de combinação de molécula biológica endógena com forma ativada potencializada de anticorpo para a sintase no endotelial. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B04C | Request for examination: application reinstated [chapter 4.3 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |